Biopharma Mfg Capacity and Production 2020

This report’s 520+ pages of data-rich analysis will help improve your decision-making in biomanufacturing operations, with in-depth analysis of capacity, production trends, benchmarks, and much more.

Coverage

• In-depth analysis of key data, capacity, production trends, and benchmarks
• Budget trends and impact of the current economic environment
• Downstream purification problems and issues
• Current and projected industry bottlenecks
• Capacity utilization and current production levels
• Capacity bottlenecks – what’s being done to resolve
• Production trends and Outsourcing trends
• International offshoring through 2025
• Range of titers, growth
• Disposables: Spending growth; downstream uses; L&E’s; reasons for increasing/ restricting; budget increases; vendor satisfaction
• Batch failure rates & trends
• Selecting a CMO — Problems & solutions
• Quality management & PAT implementation
• Hiring and employment growth
• Supplier growth rates, and much more

Compare 130+ biotherapeutic developers vs CMOs; US vs European & Global Biomanufacturing

• • Overview
  • Methodology
  • CHAPTER 0: Demographics
  • CHAPTER 1: Introduction and Discussion
  • CHAPTER 2: Overview of Critical Issues in Bioprocessing
  • CHAPTER 3: Emerging Issues in Biopharmaceutical Manufacturing
  • CHAPTER 4: Capacity Utilization
  • CHAPTER 5: Current and Future Capacity Constraints
  • CHAPTER 6: Future Capacity Expansions
  • CHAPTER 7: Outsourcing Trends in Biopharmaceutical Manufacturing
  • CHAPTER 8: Disposables and Single-Use Systems in Biopharmaceutical Manufacturing
  • CHAPTER 9: Downstream Purification
  • CHAPTER 10: Quality Issues, Batch Failures, and PAT in Biopharmaceutical Manufacturing
  • CHAPTER 11: Hiring, Employment Growth and Training in Biopharmaceutical Manufacturing
  • CHAPTER 12: New Methods: Continuous and Process Intensification, Cell and Gene Therapies [UPDATED!]
  • CHAPTER 13: Suppliers to Biopharmaceutical Manufacturing and Life Sciences

Table of Contents! 2MB

• 130+ Biopharma companies surveyed
• 150 industry vendors and direct suppliers of materials
• 33 Countries represented
• 550+ Pages
• 13 Chapters
• 200+ Graphs and 20+ Tables
• Subject Matter Experts providing analysis
• Independent Sponsoring Organizations

TESTIMONIALS for Annual Report

“Your report has delivered significant value to us. We use it as a fundamental part of the research for our strategic planning. This report has helped us see market shifts, such as the predicted increase in needs for biotech-focused CMO’s that we used to position our company to better serve our clients. We consider this a must-have report to keep our business focused in the right direction.” –Jeff Hargroves, President, ProPharma Group

“BioPlan Associates Annual Reports are a valuable independent resource for monitoring drug manufacturing activities, trends and future needs.”-Jerold Martin, Former Pall Life Sciences

“The Bioplan Annual Report and Survey is and has always been a must-read, as it is the most comprehensive survey and result analysis to determine trends, requirements and new demand of the biopharmaceutical industry. The report’s data and interpretation of the survey results are an invaluable tool for biomanufacturers and suppliers alike, as it thoroughly highlights the current status and future necessities. It not only is a snapshot report, but a multi-year evaluation.”
–Maik Jornitz, President, G-Con, LLC

“I have found each BioPlan Associates “Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production” to be particularly useful in my work. As managing editor for BioProcessing Journal, I refer to my print copies of the biomanufacturing survey reports regularly when recruiting and editing manuscripts. They are valuable components of my journal production ‘toolkit.'”-Marci J. Brown, Managing Editor, BioProcessing Journal